Hansoh Pharmaceutical Group Co., Ltd. (3692) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Sino Biopharmaceutical Ltd.

WuXi AppTec Co., Ltd.

China Medical System Holdings Ltd.

Sinopharm Group Co., Ltd.

China Resources Pharmaceutical Group Ltd.

Hygeia Healthcare Holdings Co., Ltd.

Hansoh Pharmaceutical Group Co., Ltd.

Innovent Biologics, Inc.

Akeso, Inc.

HUTCHMED (China) Ltd.

BeiGene Ltd.

Why is Hansoh Pharmaceutical Group Co., Ltd. ?

Poor long term growth as Operating profit has grown by an annual rate 10.26% of over the last 5 years

With ROE of 15.39%, it has a Very Expensive valuation with a 7.01 Price to Book Value

Over the past year, while the stock has generated a return of 60.98%, its profits have risen by 30.8% ; the PEG ratio of the company is 1.5

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Hansoh Pharmaceutical Group Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Hansoh Pharmaceutical Group Co., Ltd.

60.98%

2.71

44.67%

Hang Seng Hong Kong

8.25%

0.41

19.93%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

9.75%

EBIT Growth (5y)

10.26%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.81

Sales to Capital Employed (avg)

0.40

Tax Ratio

14.03%

Dividend Payout Ratio

42.07%

Pledged Shares

Institutional Holding

ROCE (avg)

59.55%

ROE (avg)

13.25%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

7.00

EV to EBIT

44.11

EV to EBITDA

40.04

EV to Capital Employed

33.19

EV to Sales

14.22

PEG Ratio

1.48

Dividend Yield

0.06%

ROCE (Latest)

75.24%

ROE (Latest)

15.39%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

20What is working for the Company

OPERATING CASH FLOW(Y)

Highest at HKD 11,808 MM

INTEREST COVERAGE RATIO(Q)

The company hardly has any interest cost

DIVIDEND PAYOUT RATIO(Y)

Highest at 40.84%

DIVIDEND PER SHARE(HY)

Highest at HKD 4.58

RAW MATERIAL COST(Y)

Fallen by -3.42% (YoY

CASH AND EQV(HY)

Highest at HKD 29,712.06 MM

DEBT-EQUITY RATIO (HY)

Lowest at -86.84 %

DEBTORS TURNOVER RATIO(HY)

Highest at 4.58 times

NET SALES(Q)

Highest at HKD 7,984.76 MM

OPERATING PROFIT(Q)

Highest at HKD 3,602.89 MM

OPERATING PROFIT MARGIN(Q)

Highest at 45.12 %

PRE-TAX PROFIT(Q)

Highest at HKD 3,999.83 MM

NET PROFIT(Q)

Highest at HKD 3,399.86 MM

EPS(Q)

Highest at HKD 0.57

0What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Here's what is working for Hansoh Pharmaceutical Group Co., Ltd.

Operating Cash Flow

Highest at HKD 11,808 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (HKD MM)

Dividend per share

Highest at HKD 4.58 and Grown

In each year in the last five years

MOJO Watch

Company is distributing higher dividend from profits generated

DPS (HKD)

Dividend Payout Ratio

Highest at 40.84% and Grown

In each year in the last five years

MOJO Watch

Company is distributing higher proportion of profits generated as dividend

DPR (%)

Net Sales

Highest at HKD 7,984.76 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (HKD MM)

Operating Profit

Highest at HKD 3,602.89 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (HKD MM)

Operating Profit Margin

Highest at 45.12 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit

Highest at HKD 3,999.83 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (HKD MM)

Net Profit

Highest at HKD 3,399.86 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (HKD MM)

EPS

Highest at HKD 0.57

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (HKD)

Cash and Eqv

Highest at HKD 29,712.06 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Debt-Equity Ratio

Lowest at -86.84 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Debtors Turnover Ratio

Highest at 4.58 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -3.42% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales